SEC CIK 1713517
Scanlan Jacqueline
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| HAEview stock → | 4,216 | 2021-06-07 |
| AXTAview stock → | 4,001 | 2023-08-09 |
Position History — HAE
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — HAE
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2021-06-07 | Open-market sale | 195 | $55.09 | 4,216 |
| 2021-05-19 | Open-market sale | 112 | $55.19 | 4,411 |
| 2021-05-17 | Open-market sale | 102 | $55.97 | 4,523 |
| 2021-03-08 | Open-market sale | 107 | $120.07 | 4,380 |
| 2020-06-16 | Open-market sale | 6,869 | $91.53 | 4,487 |
| 2020-06-15 | Option exercise (derivative) | 2,889 | $0.00 | 2,890 |
| 2020-06-15 | Open-market sale | 4,417 | $87.71 | 12,472 |
| 2020-06-15 | Open-market sale | 4,005 | $90.00 | 11,356 |
| 2020-06-15 | Option exercise | 2,889 | $41.64 | 15,361 |
| 2020-06-12 | Open-market sale | 111 | $89.29 | 16,889 |
| 2020-06-12 | Grant / award | 11,286 | $0.00 | 17,000 |
| 2020-06-08 | Open-market sale | 324 | $97.03 | 5,714 |
| 2020-05-18 | Grant / award (derivative) | 5,319 | $0.00 | 5,319 |
| 2020-05-18 | Grant / award | 1,572 | — | 6,038 |
| 2020-05-15 | Open-market sale | 110 | $100.44 | 4,466 |
| 2020-03-10 | Open-market sale | 207 | $99.63 | 4,383 |
| 2020-03-09 | Open-market sale | 118 | $98.00 | 4,590 |
| 2020-03-06 | Option exercise (derivative) | 1,299 | $0.00 | 1,300 |
| 2020-03-06 | Option exercise | 1,299 | $38.43 | 6,007 |
| 2020-03-06 | Open-market sale | 1,299 | $100.50 | 4,708 |
| 2019-10-09 | Open-market sale | 300 | $122.37 | 7,304 |
| 2019-10-09 | Open-market sale | 1,230 | $123.57 | 6,074 |
| 2019-10-09 | Open-market sale | 1,379 | $124.61 | 4,695 |
| 2019-10-08 | Open-market sale | 2,295 | $122.34 | 7,604 |
| 2019-10-04 | Grant / award | 5,204 | $0.00 | 9,899 |
| 2019-09-09 | Option exercise (derivative) | 1,308 | $0.00 | 3,925 |
| 2019-09-09 | Open-market sale | 1,531 | $127.44 | 4,695 |
| 2019-09-09 | Option exercise | 1,308 | $93.52 | 6,226 |
| 2019-06-17 | Option exercise (derivative) | 2,890 | $0.00 | 5,779 |
| 2019-06-17 | Open-market sale | 2,890 | $112.49 | 5,674 |
| 2019-06-17 | Open-market sale | 259 | $112.49 | 4,918 |
| 2019-06-17 | Open-market sale | 497 | $112.49 | 5,177 |
| 2019-06-17 | Option exercise | 2,890 | $41.64 | 8,564 |
| 2019-06-12 | Open-market sale | 108 | $109.37 | 5,674 |
| 2019-06-07 | Open-market sale | 208 | $103.38 | 5,782 |
| 2019-05-14 | Option exercise (derivative) | 1,299 | $0.00 | 2,599 |
| 2019-05-14 | Grant / award (derivative) | 5,342 | $0.00 | 5,342 |
| 2019-05-14 | Grant / award | 1,530 | — | 5,990 |
| 2019-05-14 | Open-market sale | 1,508 | $100.00 | 4,237 |
| 2019-05-14 | Option exercise | 1,299 | $38.43 | 5,745 |
| 2019-03-07 | Open-market sale | 116 | $83.57 | 4,446 |
| 2018-12-12 | Open-market sale | 1,027 | $104.22 | 4,562 |
| 2018-09-10 | Option exercise (derivative) | 2,889 | $0.00 | 8,669 |
| 2018-09-10 | Option exercise (derivative) | 1,299 | $0.00 | 3,898 |
| 2018-09-10 | Open-market sale | 702 | $112.19 | 5,551 |
| 2018-09-10 | Option exercise | 2,889 | $41.64 | 9,142 |
| 2018-09-10 | Open-market sale | 1,299 | $112.19 | 6,253 |
| 2018-09-10 | Option exercise | 1,299 | $38.43 | 7,552 |
| 2018-06-11 | Grant / award (derivative) | 5,233 | $0.00 | 5,233 |
| 2018-06-11 | Grant / award | 1,470 | — | 6,253 |
| 2018-06-07 | Open-market sale | 214 | $92.73 | 4,783 |
| 2018-03-06 | Open-market sale | 114 | $72.23 | 4,524 |
| 2017-07-27 | — | — | — | 4,122 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.